3863 results for «596»
3863 results
Featured research: innovations, safety and evolving pathways in modern TAVI care
16 Nov 2025 – From PCR London Valves 2025
This session addresses contemporary challenges in TAVI, including management of acute valve syndrome through service innovations and the application of Valvosoft non-invasive ultrasound therapy in severe aortic stenosis. It also explores complications such as infective endocarditis post-TAVI, evaluates the feasibility of same-day discharge protocols, and assesses...
Cutting-edge research in transcatheter tricuspid valve therapies
16 Nov 2025 – From PCR London Valves 2025
This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.
TAVI and coronary artery disease
16 Nov 2025 – From PCR London Valves 2025
This session focuses on the interplay between TAVI and coronary artery disease, discussing high-risk TAVR cases requiring complex left main PCI with prophylactic ECMO support. It provides guidance on timing and strategies for managing concomitant coronary artery disease in TAVI patients, addressing the critical decision-making process...
TAVI in bicuspid anatomy
16 Nov 2025 – From PCR London Valves 2025
Explore the complexities of performing TAVI in bicuspid aortic valve anatomies, with expert discussions on BASILICA tricuspidisation, procedural planning for extreme calcification, valve sizing, and challenges associated with type 0 bicuspid valves and severe calcification.
TAVI valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
This session presents complex valve-in-valve TAVI cases, illustrating advanced techniques such as valve fracture and snaring in difficult anatomies, approaches for pure aortic regurgitation in degenerated surgical valves, and strategies overcoming challenges in stentless bioprostheses and previous aortic repairs.
TAVI: vascular complications
16 Nov 2025 – From PCR London Valves 2025
This session examines vascular complications associated with transfemoral TAVI procedures, featuring challenging cases such as initial procedural obstacles, complex post-TAVI vascular events, and unusual complications. It also explores advanced techniques like intravascular lithotripsy to optimize TAVI outcomes in patients with severe calcific iliofemoral disease.
Curious TAVI Ssenarios: from valve-in-valve challenges to life-saving emergency TAVI
16 Nov 2025 – From PCR London Valves 2025
This session presents a series of challenging and unusual TAVI cases, addressing complex scenarios such as persistent gradients after valve-in-valve procedures, advanced sealing techniques for nodules, innovative snare methods, emergency TAVI following diagnostic catheterisation, combined aortic valve and aorta interventions, and the crucial role of echocardiography...
Late-breaking evidence in structural and coronary interventions - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...
Unusual presentations and diagnostic dilemmas
10 Oct 2025 – From AICT-AsiaPCR 2025
This session addresses unusual clinical presentations and diagnostic challenges encountered in cardiology practice. It features diverse cases including trauma-induced adrenal injury, acute chest pain in young patients, complex bifurcation stenting techniques, and intramural hematoma management, highlighting the importance of comprehensive evaluation and tailored interventional strategies.
DCB in diffuse disease and small vessels: LIVE Educational Case from National University Heart Centre - Singapore
10 Oct 2025 – From AICT-AsiaPCR 2025
This educational session focuses on the application of drug-coated balloons (DCB) in the management of diffuse coronary disease and small vessel pathology. It guides clinicians in identifying suitable lesion subsets, optimizing lesion preparation using advanced imaging and physiological assessments, and determining the appropriate timing to transition...
Coronary interventions: access, devices and outcomes
10 Oct 2025 – From AICT-AsiaPCR 2025
This session delves into the latest developments in coronary interventions, highlighting advances in vascular access techniques, innovative devices, and clinical outcomes. Topics include endothelial progenitor cell dysfunction in restenosis, the efficacy of distal radial artery (DRA) puncture and sheathless catheters in underserved areas, the use of...
New insights into mechanical circulatory support: Impella in CGS and protected PCI
10 Oct 2025 – From AICT-AsiaPCR 2025
This session provides in-depth insights into the evolving role of mechanical circulatory support, focusing on the use of Impella devices in cardiogenic shock (CGS) and protected high-risk percutaneous coronary interventions (PCI). Attendees will gain knowledge on patient selection criteria, the impact of the DanGer trial and...
Unusual and high-stakes interventions
11 Oct 2025 – From AICT-AsiaPCR 2025
This session presents a series of unusual and high-stakes interventional cardiology cases that challenge conventional approaches. It includes critical scenarios such as narrow escapes from fatal outcomes, innovative solutions like complete percutaneous repair of adult tetralogy of Fallot, and management of valve complications, providing valuable insights...
IVUS or OCT? Choosing the right imaging for the right lesion - A case-based debate
10 Oct 2025 – From AICT-AsiaPCR 2025
This case-based debate examines the complementary roles of IVUS and OCT imaging modalities in precision PCI. It highlights lesion-specific factors guiding modality choice, including left main disease, bifurcations, calcified plaques, and acute coronary syndromes, supported by real-world clinical cases demonstrating imaging-based decision-making.
Artificial intelligence and innovations in interventional cardiology
10 Oct 2025 – From AICT-AsiaPCR 2025
Explore the transformative role of artificial intelligence and robotics in interventional cardiology. This session covers big data fundamentals, bridges the gap between emerging technologies and clinical practice, and discusses AI-enhanced decision-making and robotic applications in cardiovascular interventions.
Valve and structural: challenges and innovations
11 Oct 2025 – From AICT-AsiaPCR 2025
This session explores innovative approaches and challenges in valve and structural interventions, including expanding transcatheter techniques for ruptured sinus of Valsalva closure and prophylactic chimney stenting in high-risk TAVI patients. It also presents long-term outcomes of left main PCI according to stenting methods, comparative strategies in...
Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet
19 Nov 2019 – From PCR London Valves 2019
Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!
New perspectives – Treatment of secondary mitral regurgitation in patients with heart failure
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the treatment of secondary mitral regurgitation in patients with heart failure to learn more about how to implant the Carillon Mitral Contour System, and what is the impact of cinching the mitral apparatus on regurgitant volume and left ventricular remodeling.
TAVI: management of unusual complications
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...
Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.
